Fireside chat with Water Tower Research - tomorrow at 11AM EST
heltzenpress releaseinvestor
CEO to discuss commercialization, key milestones, and potential catalysts in fireside chat with WTROctober 21, 2026
Damien Perriman on Balancing the Future podcast
press clippingspodcastperrimanNCT
Balancing the Future podcast: Cell-free bioengineering - the new chemical manufacturing frontierOctober 20, 2026
Mashable: AI is accelerating Drug Discovery. Can manufacturing keep up?
investorpress clippingsNCT
Mashable: AI is accelerating Drug Discovery. Can manufacturing keep up?October 19, 2026
Pix11 "Top Leaders" featuring EXOZ CEO, Heltzen
heltzeninvestorpress clippingsvideoNCT
Pix11 News: Reinventing How Medicine Is MadeOctober 8, 2026
Slack Capital: eXoZymes’ Path to Computational Biomanufacturing
investorpress clippings
Slack Capital: eXoZymes’ Path to Computational BiomanufacturingOctober 7, 2026
Heltzen on Grow Everything podcast, episode #201
heltzennutraceuticalspress clippingsvideoNCT
Grow Everything podcast: Out of Cell Experience - Heltzen Drives Pure ChemistryOctober 2, 2026
WTR: INITIATION OF COVERAGE REPORT
investorpress clippings
WTR: Converting Cell-Free Science into a Scalable and Repeatable Commercial OpportunityOctober 1, 2026
Globe and Mail: eXoZymes Sets Date for 2026 Shareholders Meeting
investorpress clippings
The Globe and Mail: eXoZymes Sets Date for 2026 Shareholders MeetingSeptember 19, 2026
Pharma Manufacturing: EXOZ selects Curia
press clippingsNCT
Pharma Manufacturing: eXoZymes picks Curia as commercial-scale manufacturing partnerSeptember 14, 2026
BioTuesdays: eXoZymes selects Curia as CDMO for NCT
press clippingsNCT
BioTuesdays: EXOZ selects Curia as CDMO for NCTSeptember 11, 2026
Previous page
Page 1 of 16
Next page